Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,298) with videos related to
Page
of 130
Sort By:
Nature Biotechnology
|
June 23, 2014
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
Yuan Yuan, Eliezer M Van Allen, Larsson Omberg, et al.
British Journal of Cancer
|
October 11, 2012
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V Abkevich, K M Timms, B T Hennessy, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy
Canping Chen, Kyle P Gribbin, Xi Li, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Journal for Immunotherapy of Cancer
|
December 23, 2021
Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function
Huaishan Wang, Hui Chen, Shujing Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 24, 2005
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer
Astrid M Eder, Xiaomei Sui, Daniel G Rosen, et al.
Science Advances
|
April 26, 2017
A murine preclinical syngeneic transplantation model for breast cancer precision medicine
Lorenzo Federico, Zechen Chong, Dong Zhang, et al.
Nature Cell Biology
|
February 16, 2023
Stiff matrix induces exosome secretion to promote tumour growth
Bin Wu, Di-Ao Liu, Lei Guan, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
JCI Insight
|
January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
Erin George, Hyoung Kim, Clemens Krepler, et al.
Page
of 130
Search research articles
Search
Showing results (1091-1100 of 1,298) with videos related to
Sort By:
Page
of 130
Nature Biotechnology
|
June 23, 2014
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
Yuan Yuan, Eliezer M Van Allen, Larsson Omberg, et al.
British Journal of Cancer
|
October 11, 2012
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V Abkevich, K M Timms, B T Hennessy, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy
Canping Chen, Kyle P Gribbin, Xi Li, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Journal for Immunotherapy of Cancer
|
December 23, 2021
Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function
Huaishan Wang, Hui Chen, Shujing Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 24, 2005
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer
Astrid M Eder, Xiaomei Sui, Daniel G Rosen, et al.
Science Advances
|
April 26, 2017
A murine preclinical syngeneic transplantation model for breast cancer precision medicine
Lorenzo Federico, Zechen Chong, Dong Zhang, et al.
Nature Cell Biology
|
February 16, 2023
Stiff matrix induces exosome secretion to promote tumour growth
Bin Wu, Di-Ao Liu, Lei Guan, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
JCI Insight
|
January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
Erin George, Hyoung Kim, Clemens Krepler, et al.
Page
of 130